According to the results of the RT-qPCR, CTD-2521M24.6, PAXIP1-AS2, RP11-303E16.2, RP11-360L9.7, RP11-428J1.5, AGAP2-AS1, and SBF2-AS1 were up-regulated in GBM, and RP11-513M16.7, RP11-617F23.1, and RP11-158M2.3 expressions were significantly lower compared with LGG (Figure 9B). The gene discussed is AGAP2; the disease is glioblastoma.